Your browser doesn't support javascript.
loading
Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3.
Eskelund, Christian Winther; Dimopoulos, Kostas; Kolstad, Arne; Glimelius, Ingrid; Räty, Riikka; Gjerdrum, Lise Mette Rahbek; Sonnevi, Kristina; Josefsson, Pär; Nilsson-Ehle, Herman; Bentzen, Hans H N; Fagerli, Unn Merete; Kuittinen, Outi; Haaber, Jacob; Niemann, Carsten Utoft; Pedersen, Lone Bredo; Larsen, Maria Torp; Geisler, Christian Hartmann; Hutchings, Martin; Jerkeman, Mats; Grønbæk, Kirsten.
Afiliação
  • Eskelund CW; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
  • Dimopoulos K; Biotech Research & Innovation Centre BRIC, University of Copenhagen, Denmark.
  • Kolstad A; The Danish Stem Cell Center (Danstem), University of Copenhagen, Denmark.
  • Glimelius I; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
  • Räty R; Biotech Research & Innovation Centre BRIC, University of Copenhagen, Denmark.
  • Gjerdrum LMR; The Danish Stem Cell Center (Danstem), University of Copenhagen, Denmark.
  • Sonnevi K; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Josefsson P; Unit of Experimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
  • Nilsson-Ehle H; Department of Haematology, Helsinki University Hospital, Helsinki, Finland.
  • Bentzen HHN; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Fagerli UM; Department of Clinical Medicine, University of Copenhagen, Denmark.
  • Kuittinen O; Department of Haematology, Karolinska University Hospital, Stockholm, Sweden.
  • Haaber J; Department of Haematology, Herlev Hospital, Herlev, Denmark.
  • Niemann CU; Department of Haematology, Sahlgrenska University Hospital, Göteborg, Sweden.
  • Pedersen LB; Department of Haematology, Aarhus University Hospital, Aarhus, Denmark.
  • Larsen MT; Department of Oncology, St. Olav's Hospital, Trondheim, Norway.
  • Geisler CH; Institute of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology (NTNTU), Trondheim, Norway.
  • Hutchings M; Department of Oncology, Kuopio University Hospital, Kuopio, Finland.
  • Jerkeman M; Department of Haematology, Odense University Hospital, Odense, Denmark.
  • Grønbæk K; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
Hemasphere ; 5(1): e510, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33364550
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article